Rotavirus A (RVA) is an important pathogen for porcine health. In comparison to humans, RVA in domestic animals and especially in wildlife is under researched. Therefore, the aim of the present study was to investigate the prevalence, genetic diversity, molecular epidemiology and interspecies transmission of RVA in domestic pigs and wild boars. During the three consecutive RVA seasons (2018–2021) we collected 445 and 441 samples from domestic pigs and wild boars, respectively. Samples were tested by real-time RT-PCR, and RVA-positive samples were genotyped in VP7 and VP4 segments. Our results report an RVA prevalence of 49.9% in domestic pigs and 9.3% in wild boars. Outstanding RVA genetic diversity was observed in VP7 and VP4 segments, especially in domestic pigs exhibiting a striking 23 different RVA combinations (G5P[13] and G9P[23] prevailed). Interspecies transmission events were numerous between domestic pigs and wild boars, sharing G3, G5, G6, G9, G11 and P[13] genotypes. Furthermore, our data indicate that such transmission events involved even bovines (G6, P[11]) and, intriguingly, humans (G1P[8]). This study contributes to the basic knowledge that may be considered important for vaccine development and introduction, as a valuable and currently missing tool for efficient pig health management in the EU.
Acute gastroenteritis (AGE) in cattle significantly impacts the economy due to relatively high morbidity and mortality and decreased production. Its multifactorial nature drives its global persistence, involving enteric viruses, bacteria, protozoa, and environmental factors. Bovine Rotavirus A (BoRVA) and bovine coronavirus (BCoV) are among the most important enteric RNA viruses causing AGE in cattle. These viruses infect intestinal enterocytes, leading to cell damage and consequently to malabsorption and diarrhea. BoRVA primarily affects calves under 14 days old with gastrointestinal clinical signs, while BCoV affects all ages, causing gastrointestinal and respiratory distress. The economic impact of BoRVA and BCoV, along with their interspecies transmission potential, warrants attention. This concise review discusses the molecular structure, epidemiology, pathogenesis, clinical signs, diagnosis, treatment, and preventive measures of BoRVA and BCoV while providing a comparative analysis. By offering practical guidance on managing such viral infections in cattle, these comparative insights may prove valuable for veterinarians in clinical practice.
Adipose tissue, previously known as connective tissue with a role in energy storage, is currently changing the course of treatments in veterinary medicine. Recent studies have revealed one particularly impressive function among all the newly discovered functions of adipose tissue. The interactive cells hosted by adipose tissue, the stromal vascular fraction (SVF), and their role in treating numerous diseases have provided a prospective course of research with positive outcomes in regenerative veterinary medicine (RVM). This review describes the main features of adipose tissue, emphasizing an eclectic combination of cells within the SVF and its thus far researched therapeutic possibilities in canine RVM. An afterwards focus is on a highly researched component of the SVF, adipose-derived mesenchymal stem cells (ASCs), which were shown to have an extraordinary impact relying on several proposed mechanisms of action on mitigating pathologies in canines. Furthermore, ASC therapy showed the most significant results in the orthopaedics field and in neurology, dermatology, ophthalmology, gastroenterology, and hepatology, which elevates the possibilities of ASC therapy to a whole new level. Therefore, this review article aims to raise awareness of the importance of research on cellular components, within abundant and easily accessible adipose tissue, in the direction of regenerative therapy in canines, considering the positive outcomes so far. Although the focus is on the positive aspects of cellular therapy in canines, the researchers should not forget the importance of identifying the potential negative aspects within published and upcoming research. Safe and standardized treatment represents a fundamental prerequisite for positively impacting the lives of canine patients.
The experimental application of canine adipose-derived mesenchymal stem/stromal cells (cAD-MSC) has demonstrated excellent therapeutic potential in the treatment of a number of previously untreatable or difficult-to-treat diseases. However, the production of cAD-MSC for clinical application necessitates in vitro isolation and cell expansion, introducing the risk of microbiological contamination. Studies indicate that stored MSCs may be contaminated with bacteria, fungi, or viruses, resulting in cell transformation, cell death, or persistent infection. This ultimately compromises therapeutic efficacy and potentially facilitates therapy-induced pathogen transmission. In accordance with the European Medicines Agency guidelines mandating sterility testing as an integral component of the manufacturing process, this study aimed to assess the sterility of the cAD-MSC bank at the Croatian Veterinary Institute. To test for the most clinically significant canine pathogens, nucleic acids were extracted from 32 cAD-MSC preparations and analyzed using standard molecular PCR methods. The pathogen screening panel included rabies virus (Lyssavirus), canine herpesvirus (Varicellovirus canidalpha1), parvovirus (Carnivore protoparvovirus 1), coronavirus (Alphacoronavirus 1), distemper virus (Morbillivirus canis), Rotavirus A, Leptospira spp, Brucella canis, Borrelia burgdorferi sensu lato, Anaplasma spp, Ehrlichia spp, Mycoplasma spp (hemotropic), and Neospora caninum. No tested gene fragments of the aforementioned pathogens were detected, indicating that the cAD-MSC preparations were free from the presence of clinically significant pathogens. Rigorous implementation of sterility control during the cell isolation and expansion process is essential to ensure safe cell-based therapy in canine patients.